title: Practicalities of nutrition support in the intensive care unit: the usefulness of gastric residual volume and prokinetic agents with enteral nutrition.
abstract: The provision of early nutrition therapy to critically ill patients is established as the standard of care in most intensive care units around the world. Despite the known benefits, tolerance of enteral nutrition in the critically ill varies and delivery is often interrupted. Observational research has demonstrated that clinicians deliver little more than half of the enteral nutrition they plan to provide. The main clinical tool for assessing gastric tolerance is gastric residual volume; however, its usefulness in this setting is debated. There are several strategies employed to improve the tolerance and hence adequacy of enteral nutrition delivery in the critically ill. One of the most widely used strategies is that of prokinetic drug administration, most commonly metoclopramide and erythromycin. Although there are new agents being investigated, none are ready for routine application in the critically ill and the benefits are still being established. This review investigates current practice and considers the literature on assessment of enteral tolerance and optimization of enteral nutrition in the critically ill.
authors.affiliation: Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia. emma.ridley@monash.edu
authors.forename: Emma J
authors.initials: EJ
authors.lastname: Ridley
authors.forename: Andrew R
authors.initials: AR
authors.lastname: Davies
mesh_terms: D016638:Critical Illness / Q000628:therapy; D004750:Enteral Nutrition / Q000592:standards*; D004917:Erythromycin / Q000008:administration & dosage / Q000627:therapeutic use; D005746:Gastric Emptying; D005753:Gastric Mucosa / Q000378:metabolism; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007362:Intensive Care Units / Q000592:standards*; D008787:Metoclopramide / Q000008:administration & dosage / Q000627:therapeutic use; D059039:Standard of Care; D013270:Stomach / Q000503:physiopathology*
chemical_list: D005765:Gastrointestinal Agents; D004917:Erythromycin; D008787:Metoclopramide